Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 8.

Schlinkmann, K M; Honegger, A; Tureci, E; Robison, K E; Lipovsek, D; Pluckthun, A (2012). Critical features for biosynthesis, stability, and functionality of a G protein-coupled receptor uncovered by all-versus-all mutations. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 109(25):9810-9815.

Stefan, N; Martin-Killias, P; Wyss-Stoeckle, S; Honegger, A; Zangemeister-Wittke, U; Plückthun, A (2011). DARPins recognizing the tumor-associated antigen EpCAM selected by phage and ribosome display and engineered for multivalency. Journal of Molecular Biology, 413(4):826-43.

Schaefer, J V; Honegger, A; Plückthun, A (2010). Construction of scFv fragments from hybridoma or spleen cells by PCR assembly. In: Kontermann, R; Dübel, S. Antibody Engineering. Berlin Heidelberg: Springern-Verlag, 21-44.

Kügler, M; Stein, C; Schwenkert, M; Saul, D; Vockentanz, L; Huber, T; Wetzel, S K; Scholz, O; Plückthun, A; Honegger, A; Fey, G H (2009). Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework. Protein Engineering Design and Selection : PEDS, 22(3):135-147.

Honegger, A; Malebranche, A D; Röthlisberger, D; Plückthun, A (2009). The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains. Protein Engineering Design and Selection : PEDS, 22(3):121-134.

Rothe, C; Urlinger, S; Löhning, C; Prassler, J; Stark, Y; Jäger, U; Hubner, B; Bardroff, M; Pradel, I; Boss, M; Bittlingmaier, R; Bataa, T; Frisch, C; Brocks, B; Honegger, A; Urban, M (2008). The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. Journal of Molecular Biology, 376(4):1182-1200.

Honegger, A (2008). Engineering antibodies for stability and efficient folding. In: Chernajovsky, Y; Nissim, A. Therapeutic Antibodies. Berlin, Heidelberg: Springer, 47-68.

Röthlisberger, D; Honegger, A; Plückthun, A (2005). Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. Journal of Molecular Biology, 347(4):773-789.

This list was generated on Mon Jun 25 20:37:39 2018 CEST.